Expired Study
This study is not currently recruiting Study Participants on ClinicalConnection.com. If you would like to find active studies please search for clinical trials.

Los Angeles, California 90095


Purpose:

Men who are scheduled for radical prostatectomy are considered candidates for this study. Six weeks prior to surgery, the subject will undergo screening procedures to determine eligibility. If eligible, the subject will be randomized to one of two four-week nutrition programs - either a balanced Western Diet or a low-fat diet with fish oil capsules. The UCLA GCRC (General Clinical Research Center) chefs will prepare breakfast, lunch, and dinner, and meals will be delivered to subjects in coolers two days per week. Subjects will require a minimum of four visits to the UCLA GCRC.


Study summary:

Experiments have shown that a low fat diet high in fish oil may prevent the progression of prostate cancer. The purpose of this study is to determine if a low-fat diet combined with fish oil capsules will change the chemical substances present in blood and prostate tissue that are related to the growth of cancer cells. This study will compare how these substances are affected by either, a typical high-fat Western diet, or a low-fat diet combined with fish oil.


Criteria:

Inclusion Criteria: - Has been diagnosed with adenocarcinoma (cancer) - Able to sign the consents to participate. - Is medically able to receive and comply with the dietary intervention. - Accessible geographically and by telephone for nutritional counseling and follow up. - Has elected to undergo radical prostatectomy. - Agrees to stop taking dietary or vitamin supplements (Lycopene, Vitamin E, selenium, genistein) or herbal supplements (eg. saw palmetto, PC-SPES) for 1 week prior to starting the study. - Can safely stop taking aspirin, COX-2 inhibitors, and other anti-inflammatory medications for 1 week prior to starting the study. - Can safely stop taking fish oil capsules 2-weeks prior to starting the diet intervention. Exclusion Criteria: - Is taking LHRH agonists, androgen receptor blocking agents or finasteride. - Has undergone bilateral orchiectomy. - Has a bleeding disorder.


NCT ID:

NCT00836615


Primary Contact:

Principal Investigator
William Aronson, MD
University of California, Los Angeles


Backup Contact:

N/A


Location Contact:

Los Angeles, California 90095
United States



There is no listed contact information for this specific location.

Site Status: N/A


Data Source: ClinicalTrials.gov

Date Processed: October 09, 2019

Modifications to this listing: Only selected fields are shown, please use the link below to view all information about this clinical trial.


Click to view Full Listing

This study is not currently recruiting Study Participants on ClinicalConnection.com. The form below is not enabled.